In a report released today, Dylan Van Haaften from Stifel Nicolaus maintained a Buy rating on Straumann Holding AG (STMN – Research Report), with a price target of CHF140.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Dylan Van Haaften’s rating is based on Straumann Holding AG’s strong financial performance and growth prospects. The company reported impressive top-line results, with organic growth significantly surpassing market expectations. This was particularly evident in the Asia Pacific region, where growth was driven by high volumes and successful product launches.
Despite some concerns about slower growth in North America and a cautious consumer environment, Straumann’s performance in Europe, the Middle East, and Africa, as well as Latin America, remained robust. The company’s strategic initiatives, such as the iEXCEL implant system and ClearCorrect orthodontics, contributed to its strong market position. These factors, combined with confirmed guidance for improved revenue growth and EBIT margins, underpin the Buy rating.
In another report released on April 28, Kepler Capital also maintained a Buy rating on the stock with a CHF150.00 price target.